BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11871661)

  • 1. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    Mehta A; Driscoll DM
    RNA; 2002 Jan; 8(1):69-82. PubMed ID: 11871661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mehta A; Kinter MT; Sherman NE; Driscoll DM
    Mol Cell Biol; 2000 Mar; 20(5):1846-54. PubMed ID: 10669759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.
    Blanc V; Navaratnam N; Henderson JO; Anant S; Kennedy S; Jarmuz A; Scott J; Davidson NO
    J Biol Chem; 2001 Mar; 276(13):10272-83. PubMed ID: 11134005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.
    Anant S; Henderson JO; Mukhopadhyay D; Navaratnam N; Kennedy S; Min J; Davidson NO
    J Biol Chem; 2001 Dec; 276(50):47338-51. PubMed ID: 11577082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.
    Blanc V; Henderson JO; Kennedy S; Davidson NO
    J Biol Chem; 2001 Dec; 276(49):46386-93. PubMed ID: 11571303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    Sowden MP; Ballatori N; Jensen KL; Reed LH; Smith HC
    J Cell Sci; 2002 Mar; 115(Pt 5):1027-39. PubMed ID: 11870221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3' untranslated region of c-myc increases mRNA stability.
    Anant S; Davidson NO
    Mol Cell Biol; 2000 Mar; 20(6):1982-92. PubMed ID: 10688645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing.
    Lau PP; Zhu HJ; Nakamuta M; Chan L
    J Biol Chem; 1997 Jan; 272(3):1452-5. PubMed ID: 8999813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    Sowden MP; Lehmann DM; Lin X; Smith CO; Smith HC
    J Biol Chem; 2004 Jan; 279(1):197-206. PubMed ID: 14570923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.
    Mehta A; Driscoll DM
    Mol Cell Biol; 1998 Aug; 18(8):4426-32. PubMed ID: 9671452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome.
    Lau PP; Chang BH; Chan L
    Biochem Biophys Res Commun; 2001 Apr; 282(4):977-83. PubMed ID: 11352648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.
    MacGinnitie AJ; Anant S; Davidson NO
    J Biol Chem; 1995 Jun; 270(24):14768-75. PubMed ID: 7782343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.
    Sowden MP; Eagleton MJ; Smith HC
    Nucleic Acids Res; 1998 Apr; 26(7):1644-52. PubMed ID: 9512534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
    Mukhopadhyay D; Anant S; Lee RM; Kennedy S; Viskochil D; Davidson NO
    Am J Hum Genet; 2002 Jan; 70(1):38-50. PubMed ID: 11727199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing.
    Lau PP; Villanueva H; Kobayashi K; Nakamuta M; Chang BH; Chan L
    J Biol Chem; 2001 Dec; 276(49):46445-52. PubMed ID: 11584023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARCD-1, an apobec-1-related cytidine deaminase, exerts a dominant negative effect on C to U RNA editing.
    Anant S; Mukhopadhyay D; Sankaranand V; Kennedy S; Henderson JO; Davidson NO
    Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1904-16. PubMed ID: 11698249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct promoters induce APOBEC-1 expression in rat liver and intestine.
    Greeve J; Axelos D; Welker S; Schipper M; Greten H
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1079-92. PubMed ID: 9672068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
    Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
    J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.
    Lellek H; Kirsten R; Diehl I; Apostel F; Buck F; Greeve J
    J Biol Chem; 2000 Jun; 275(26):19848-56. PubMed ID: 10781591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of mRNA editing in yeast using a Gal4-apoB-Gal80 fusion transcript as the selectable marker.
    Lellek H; Welker S; Diehl I; Kirsten R; Greeve J
    J Biol Chem; 2002 Jun; 277(26):23638-44. PubMed ID: 11976346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.